CD4 and obstructive sleep apnea syndrome: Our data indicate that alterations in TUFM expression in CD4+ T cells may provide an important biological foundation for immunological dysfunction in OSA patients, offering a theoretical framework for the development of therapeutic options targeting mitochondrial function in OSA.